These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 122676)

  • 1. An outline of D-penicillamine metabolism.
    Perrett D
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):61-4. PubMed ID: 122676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism and pharmacology of D-penicillamine in man.
    Perrett D
    J Rheumatol Suppl; 1981; 7():41-50. PubMed ID: 7014876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of albumin conjugates of D-penicillamine in humans.
    Joyce DA; Day RO; Murphy BR
    Drug Metab Dispos; 1991; 19(2):309-11. PubMed ID: 1676628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism and disposition of D-penicillamine in the DA-strain rat.
    Pilkington AE; Waring RH
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):99-104. PubMed ID: 3208797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis.
    Yu TF; Roboz J; Johnson S; Kaung C
    J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of 35S-D-penicillamine in man.
    Waring RH; Mitchell SC
    Xenobiotica; 1988 Feb; 18(2):235-44. PubMed ID: 3376495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on in vivo decarboxylation of D-penicillamine in rats.
    Kucharczyk N; Wong KK; Yang JT; Sofia RD
    Arzneimittelforschung; 1984; 34(2):211-2. PubMed ID: 6426483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of assay methods for D-penicillamine.
    Kucharczyk N; Shahinian S
    J Rheumatol Suppl; 1981; 7():28-34. PubMed ID: 6939884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and excretion of ropivacaine in humans.
    Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in response to D-penicillamine: pharmacokinetic insights.
    Joyce DA
    Agents Actions Suppl; 1993; 44():203-7. PubMed ID: 8372729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and metabolism of D- and L-penicillamine. 1. Blood level, transport and protein binding].
    Ruiz-Torres A
    Arzneimittelforschung; 1974 Jun; 24(6):914-7. PubMed ID: 4408088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic studies after oral application of radioactively labelled D-penicillamine].
    Patzschke K; Wegner L; Kaller H; Horster FA
    Z Rheumatol; 1977; 36(3-4):96-105. PubMed ID: 871071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology and mechanism of action of D-penicillamine in rheumatoid polyarthritis].
    Clerc D; Sallière D; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1983 May; 50(6):457-63. PubMed ID: 6351235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of D-penicillamine in man.
    Wiesner RH; Dickson ER; Carlson GL; McPhaul LW; Go VL
    J Rheumatol Suppl; 1981; 7():51-5. PubMed ID: 6939886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-penicillamine pharmacokinetics and action.
    Joyce DA
    Agents Actions Suppl; 1988; 24():197-206. PubMed ID: 3263758
    [No Abstract]   [Full Text] [Related]  

  • 20. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.